Lutein attenuates angiotensin II- induced cardiac remodeling by inhibiting AP-1/IL-11 signaling

Youming Chen,Lan Wang,Shixing Huang,Jiangfeng Ke,Qing Wang,Zhiwen Zhou,Wei Chang

DOI: https://doi.org/10.1016/j.redox.2021.102020

IF: 11.4

2021-08-01

Redox Biology

Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Rationale</h3><p>Oxidative stress plays a critical role in the development of cardiac remodeling and heart failure. Lutein, the predominant nonvitamin A carotenoid, has been shown to have profound effects on oxidative stress. However, the effect of lutein on angiotensin II (Ang II)-induced cardiac remodeling and heart failure remains unknown.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objective</h3><p>The aim of this study was to determine whether lutein is involved in cardiac remodeling and to elucidate the underlying molecular mechanisms.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods and results</h3><p>In vitro experiments with isolated neonatal rat cardiomyocytes (NRCMs) and cardiac fibroblasts (CFs) revealed that lutein significantly attenuated Ang II-induced collagen expression in CFs, and cardiomyocyte hypertrophy. The Ang II-induced increases in superoxide generation, inflammation and apoptosis in cultured CFs were strikingly prevented by lutein. In vivo, fibrosis, hypertrophic cardiomyocyte and superoxide generation were analyzed, and lutein was demonstrated to confer resistance to Ang II-induced cardiac remodeling in mice. Mechanistically, RNA sequencing revealed that interleukin-11 (IL-11) expression was significantly upregulated in mouse hearts in response to Ang II infusion and was significantly suppressed in the hearts of lutein-treated mice. Furthermore, IL-11 overexpression blocked the effects of lutein on fibrosis and oxidative stress in CFs and impaired the protective effect of lutein on cardiac remodeling. Notably, we discovered that lutein could reduce Ang II-induced IL-11 expression, at least partly through the regulation of activator protein (AP)-1 expression and activity.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>Lutein has potential as a treatment for cardiac remodeling and heart failure via the suppression of IL-11 expression.</p>

biochemistry & molecular biology

What problem does this paper attempt to address?

The paper primarily explores the role of Lutein in inhibiting Angiotensin II (Ang II)-induced cardiac remodeling and its potential molecular mechanisms. ### Research Background and Objectives - Heart failure is a global health issue, and cardiac remodeling caused by hypertension is a common cause of heart failure. - Pathological cardiac remodeling typically manifests as left ventricular hypertrophy and interstitial fibrosis, which significantly reduce the compliance of myocardial tissue and lead to contractile dysfunction. - Angiotensin II (Ang II), as the main mediator of the renin-angiotensin-aldosterone system (RAAS), plays a key role in various cardiovascular diseases. - Although Lutein has been proven to have biological effects such as anti-inflammatory and antioxidant properties, its role and mechanism in hypertensive cardiac remodeling have not been elucidated. ### Main Research Content - In vitro experiments found that Lutein can significantly reduce Ang II-induced hypertrophy of neonatal rat cardiomyocytes (NRCMs) and increased collagen expression in cardiac fibroblasts (CFs). - Lutein can effectively inhibit Ang II-induced superoxide production, inflammatory response, and apoptosis. - In in vivo experiments with mice, Lutein can reduce Ang II-induced fibrosis, cardiomyocyte hypertrophy, and superoxide production. - Mechanistically, RNA sequencing results showed that Ang II can significantly upregulate the expression level of IL-11 in the mouse heart, while Lutein treatment can significantly inhibit this process. - Further studies indicated that Lutein reduces IL-11 expression by regulating the expression and activity of activator protein (AP-1), thereby inhibiting the occurrence of cardiac remodeling. ### Conclusion Lutein may serve as a new therapeutic approach for cardiac remodeling and heart failure, with its mechanism at least partially achieved by inhibiting IL-11 expression.

Lutein attenuates angiotensin II- induced cardiac remodeling by inhibiting AP-1/IL-11 signaling

LUTEOLIN REDUCES CARDIAC DYSFUNCTIONS AND MITOCHONDRIAL OXIDATIVE STRESS IN STREPTOZOTOCIN‐INDUCED DIABETIC RATS

[Luteolin Reduces Cardiac Dysfunctions in Streptozotocin-Induced Diabetic Rats].

Cardioprotective Effects of Luteolin on Ischemia/reperfusion Injury in Diabetic Rats Are Modulated by Enos and the Mitochondrial Permeability Transition Pathway.

Luteolin attenuates angiotensin II‐induced renal damage in apolipoprotein E‐deficient mice

Lutein suppresses ferroptosis of cardiac microvascular endothelial cells via positive regulation of IRF in cardiac hypertrophy

Low‐intensity Pulsed Ultrasound Ameliorates Angiotension Ii-induced Cardiac Fibrosisbyalleviating Inflammation via a Caveolin-1-dependent Pathway

Luteolin Protects Cardiomyocytes Cells against Lipopolysaccharide-Induced Apoptosis and Inflammatory Damage by Modulating Nlrp3

Luteolin alleviates post-infarction cardiac dysfunction by up-regulating autophagy through Mst1 inhibition.

Luteolin ameliorates cardiac failure in type I diabetic cardiomyopathy

Luteolin Attenuates Cardiac Ischemia/Reperfusion Injury in Diabetic Rats by Modulating Nrf2 Antioxidative Function

LTBP2 Knockdown Ameliorates Cardiac Fibrosis and Apoptosis via Attenuating NF‐κB Signaling Pathway and Oxidative Stress in Mice with Cardiac Hypertrophy

Biomimetic nanoparticles loaded lutein functionalized by macrophage membrane for targeted amelioration pressure overload-induced cardiac fibrosis

Kaempferol Prevents Against Ang II-induced Cardiac Remodeling Through Attenuating Ang II-induced Inflammation and Oxidative Stress.

Apelin-13 alleviated cardiac fibrosis via inhibiting the PI3K/Akt pathway to attenuate oxidative stress in rats with myocardial infarction-induced heart failure

Irisin Ameliorates Angiotensin II‐induced Cardiomyocyte Apoptosis Through Autophagy

Luteolin Pretreatment Ameliorates Myocardial Ischemia/Reperfusion Injury by lncRNA-JPX/miR-146b Axis

Luteolin-7-diglucuronide Attenuates Isoproterenol-Induced Myocardial Injury and Fibrosis in Mice

Rhein attenuates angiotensin II-induced cardiac remodeling by modulating AMPK–FGF23 signaling

LCZ696, an Angiotensin Receptor-Neprilysin Inhibitor, Improves Cardiac Hypertrophy and Fibrosis and Cardiac Lymphatic Remodeling in Transverse Aortic Constriction Model Mice

Luteolin Limits Infarct Size and Improves Cardiac Function after Myocardium Ischemia/reperfusion Injury in Diabetic Rats.